Advertisement
Sino Biological
Sino Biological

Most Recent

image: Passing On Stress

Passing On Stress

By | May 22, 2012

Exposure to an environmental toxin can affect future generations’ ability to handle stressful conditions.

4 Comments

image: Genome Digest

Genome Digest

By | May 22, 2012

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: How Castor Oil Stimulates Labor

How Castor Oil Stimulates Labor

By | May 21, 2012

Researchers flag the EP3 prostaglandin receptor as a key player in castor oil’s laxative and labor-inducing effects.

0 Comments

image: HIV Prevention Debate

HIV Prevention Debate

By | May 21, 2012

The suggested approval of a widely used antiretroviral drug to prevent HIV transmission in uninfected people sparks a debate about the possible dangers of such a move.

1 Comment

image: US Drug Approvals Top Canada, Europe

US Drug Approvals Top Canada, Europe

By | May 18, 2012

The FDA approves drugs faster and earlier than regulatory agencies in other countries.

3 Comments

image: Gene Therapy for Brain Disease

Gene Therapy for Brain Disease

By | May 16, 2012

Delivering a missing enzyme to the brains of paralyzed children with a rare, life-threatening neurological disease restores movement and builds muscle mass.

0 Comments

image: FDA Eases Sterility Requirements

FDA Eases Sterility Requirements

By | May 16, 2012

The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.

1 Comment

image: Does Education Boost Health?

Does Education Boost Health?

By | May 15, 2012

An examination of Swedish health and educational records suggests that more schooling results in healthier adults.

2 Comments

image: Bionic Eye Sees the Light

Bionic Eye Sees the Light

By | May 15, 2012

A light-powered retinal implant restores vision in rats.

0 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
The Scientist
The Scientist
Advertisement
NeuroScientistNews
NeuroScientistNews
Life Technologies